rs59962885
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM1PM2PM5BS1_Supporting
The NM_001927.4(DES):c.1009G>A(p.Ala337Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000359 in 1,613,398 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A337P) has been classified as Pathogenic.
Frequency
Consequence
NM_001927.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DES | ENST00000373960.4 | c.1009G>A | p.Ala337Thr | missense_variant | Exon 5 of 9 | 1 | NM_001927.4 | ENSP00000363071.3 | ||
DES | ENST00000477226.6 | n.483G>A | non_coding_transcript_exon_variant | Exon 4 of 8 | 4 | |||||
DES | ENST00000492726.1 | n.404G>A | non_coding_transcript_exon_variant | Exon 4 of 6 | 4 | |||||
DES | ENST00000683013.1 | n.397G>A | non_coding_transcript_exon_variant | Exon 3 of 7 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000679 AC: 17AN: 250286Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135336
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461292Hom.: 0 Cov.: 38 AF XY: 0.0000371 AC XY: 27AN XY: 726926
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: DES c.1009G>A (p.Ala337Thr) results in a non-conservative amino acid change located in the Intermediate filament, rod domain (IPR039008) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-05 in 250286 control chromosomes (gnomAD). The observed variant frequency is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in DES causing Dilated Cardiomyopathy phenotype (3.1e-05), strongly suggesting that the variant is benign. c.1009G>A has been reported in the literature in individuals from cohorts of hypertrophy cardiomyopathy/dilated cardiomyopathy /sudden death that had panel testing (example: Lin_2017, McGurk_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 29247119, 37652022). ClinVar contains an entry for this variant (Variation ID: 382176). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Desmin-related myofibrillar myopathy Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 337 of the DES protein (p.Ala337Thr). This variant is present in population databases (rs59962885, gnomAD 0.03%). This missense change has been observed in individual(s) with sudden unexplained death (PMID: 29247119). ClinVar contains an entry for this variant (Variation ID: 382176). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DES protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1I Uncertain:1
The missense c.1009G>A (p.Ala337Thr) variant in the DES gene has been detected in a sudden death cohort, and in a non_x0002_compaction cardiomyopathy cohort; however, details are limited (van Waning, Jaap I et al., 2018; Lin, Ying et al., 2017). This variant is reported with the allele frequency (0.006%) in the gnomAD Exomes and novel in 1000 Genomes. It is submitted to ClinVar as Uncertain Significance. The amino acid Alanine at position 337 is changed to a Threonine changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Ala337Thr in DES is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance -
Desmin-related myofibrillar myopathy;C1858154:Dilated cardiomyopathy 1I;C1867005:Neurogenic scapuloperoneal syndrome, Kaeser type Uncertain:1
- -
not provided Uncertain:1
Identified in patients with DCM, sudden death, and non-compaction cardiomyopathy (NCCM) in published literature (PMID: 37652022, 29247119, 29447731); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32906206, 26807690, 29247119, 37652022, 29447731) -
Cardiovascular phenotype Uncertain:1
The p.A337T variant (also known as c.1009G>A), located in coding exon 5 of the DES gene, results from a G to A substitution at nucleotide position 1009. The alanine at codon 337 is replaced by threonine, an amino acid with similar properties. This variant has been detected in a sudden death cohort, and in a non-compaction cardiomyopathy cohort; however, details were limited (Lin Y et al. Circ Cardiovasc Genet, 2017 Dec;10; van Waning JI et al. J. Am. Coll. Cardiol., 2018 02;71:711-722). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at